Publications by authors named "Peter F Troke"

Claim this Profile
N
Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase.
Jessamine G Goh, Sharada Ravikumar, Mar Soe Win, Qiong Cao, Ai Ling Tan, Peter F Troke

Cell Microbiol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
Louis Yi Ann Chai, Bart Jan Kullberg, Arul Earnest, Elizabeth M Johnson, Steven Teerenstra, Peter F Troke

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue penetration of antifungal agents.
Timothy Felton, Peter F Troke, William W Hope

Clin Microbiol Rev· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity.
Louis Y A Chai, Mihai G Netea, Bee Choo Tai, Lay Wai Khin, Alieke G Vonk, Peter F Troke

J Antimicrob Chemother· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis.
Louis Y A Chai, Bart-Jan Kullberg, Elizabeth M Johnson, Steven Teerenstra, Lay Wai Khin, Peter F Troke

J Clin Microbiol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.
Peter F Troke, Hans P Hockey, William W Hope

Antimicrob Agents Chemother· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early proinflammatory cytokines and C‐reactive protein trends as predictors of outcome in invasive Aspergillosis.
Louis A Chai, Mihai G Netea, Steven Teerenstra, Arul Earnest, Alieke G Vonk, Peter F Troke

J Infect Dis· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
Roger J M Brüggemann, N M A Blijlevens, David M Burger, Barbara Franke, Peter F Troke

J Antimicrob Chemother· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients.
Jonathan Lambourne, Dan Agranoff, Raoul Herbrecht, Peter F Troke, Aby Buchbinder

Clin Infect Dis· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.
Reginald E Greene, Haran T Schlamm, Jörg-W Oestmann, Paul Stark, Christine Durand, Peter F Troke

Clin Infect Dis· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of voriconazole and dose individualization.
Irja Lutsar, Mike R Hodges, Konrad Tomaszewski, Peter F Troke, Nolan D Wood

Clin Infect Dis· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Raoul Herbrecht, David W Denning, Thomas F Patterson, John E Bennett, Reginald E Greene, Peter F Troke

N Engl J Med· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis